SB 430 Kansas Senate · 2025-2026 Regular Session

Adding mitragynine to schedule I of the uniform controlled substances act and reconciling multiple amendments to certain statutes in the Kansas criminal code.

SB 430 allows licensed physical therapists in Kansas to perform specific fingerstick blood tests (like lactate and blood glucose) to assess muscle metabolism, exercise tolerance, or rehabilitation progress. It limits these tests to federal "CLIA-waved" assays, requires therapists to hold a federal waiver certificate, and mandates that results only support therapy planning or follow physician orders - never for diagnosing medical conditions. Physical therapists cannot bill insurance for these tests alone but may charge patients for supply costs. The bill explicitly prevents therapists from expanding their diagnostic authority or billing separately for these tests.
Bill status signed all 5 stages cleared
Introduction
Jan 2026
Committee Review
Apr 2026
Senate Passage
Feb 2026
House Passage
Apr 2026
Signed into Law
Apr 2026
Introduced Jan 30, 2026 Signed Apr 10, 2026
Maddy AI version diff · 3 comparisons

What changed between versions

As Amended by Senate Committee As Amended by House Committee · 3 edits
MINOR
The bill was amended by the House Committee to correct a technical error in the definition of 'CLIA-waived tests' and to add a new requirement for written patient consent. The House also added a new subsection (g) to Section 1, which mandates that physical therapists must obtain written consent before performing point-of-care testing. This consent must explicitly disclose costs and confirm the patient's financial responsibility for the supplies used.
Scope change
The bill's scope of applicability remains the same, but the requirements for physical therapists performing tests have been expanded to include a mandatory consent process.
TECHNICAL

Corrected a typo in the definition of 'CLIA-waived tests' to include the word 'tests' after 'waived'.

REQUIREMENT

Added a new requirement that physical therapists must obtain written consent from patients before performing point-of-care testing.

Specified that the written consent must include a disclosure of costs and an acknowledgment of financial responsibility.

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
20
Key actions
15
Committee
8
Apr 10, 2026
Signed into law
Approved by Governor on Monday, April 27, 2026
upper
Apr 10, 2026
Upper · Passed
Conference Committee Report was adopted; Yea 38, Nay 0, Absent 1
upper
Apr 10, 2026
Lower · Passed
Conference Committee Report was adopted; Yea 78, Nay 44, Absent 3
lower
Apr 10, 2026
Lower · Passed
Motion to suspend Joint Rule 4 (k) to allow consideration adopted
lower
Apr 10, 2026
Lower · Passed
Conference committee report now available
lower
Mar 23, 2026
Lower · Passed
Motion to accede adopted; Rep. Will Carpenter, Rep. Ron Bryce and Rep. Susan Ruiz appointed as conferees
lower
Mar 23, 2026
Upper · Passed
Nonconcurred with amendments; Conference Committee requested; appointed Sen. Beverly Gossage, Sen. William Clifford and Sen. Cindy Holscher
upper
Mar 12, 2026
Lower · Passed
Final Action - Passed as amended; Yea 101, Nay 18, Absent 5
lower
Mar 11, 2026
Lower · Passed
Committee of the Whole - Be passed as amended
lower
Mar 11, 2026
Lower · Passed
Committee of the Whole - Committee Report be adopted
lower
Mar 9, 2026
Lower · Passed
Committee Report recommending bill be passed as amended by House Committee on Health and Human Services
lower
Feb 25, 2026
Committee
Referred to House Committee on Health and Human Services
lower
Feb 25, 2026
Introduced
Received and Introduced
lower
Feb 18, 2026
Upper · Passed
Emergency Final Action - Passed as amended; Yea 40, Nay 0
upper
Feb 18, 2026
Upper · Passed
Committee of the Whole - Be passed as amended
upper
Feb 18, 2026
Upper · Passed
Committee of the Whole - Committee Report be adopted
upper
Feb 12, 2026
Upper · Passed
Committee Report recommending bill be passed as amended by Senate Committee on Public Health and Welfare
upper
Feb 2, 2026
Committee
Referred to Senate Committee on Public Health and Welfare
upper
Jan 30, 2026
Introduced
Introduced
upper
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.